Vesper DUO Venous Stent System
Symptomatic Chronic Venous Insufficiency (CVI) due to iliac and/or common femoral vein obstruction
Phase 3Active
Key Facts
Indication
Symptomatic Chronic Venous Insufficiency (CVI) due to iliac and/or common femoral vein obstruction
Phase
Phase 3
Status
Active
Company
About Vesper Medical
Vesper Medical is a private, clinical-stage medical device company developing specialized stents for deep venous disease, specifically Chronic Venous Insufficiency (CVI). Its lead program, the Vesper DUO Venous Stent System, is under investigation in the VIVID clinical trial, which has completed patient enrollment. The company was founded in 2017 as a spinout from Intact Vascular and was subsequently acquired by Royal Philips, providing strategic backing and a pathway to commercialization within a larger medtech portfolio.
View full company profile